Tumor Microenvironment-Modulated Nanozymes for NIR-II-Triggered Hyperthermia-Enhanced Photo-Nanocatalytic Therapy via Disrupting ROS Homeostasis
Lipeng Zhu,Yunlu Dai,Lizeng Gao,Qi Zhao
DOI: https://doi.org/10.2147/ijn.s309062
IF: 7.033
2021-07-05
International Journal of Nanomedicine
Abstract:Lipeng Zhu, 1 Yunlu Dai, 1, 2 Lizeng Gao, 3 Qi Zhao 1, 2 1 Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, People's Republic of China; 2 MoE Frontiers Science Center for Precision Oncology, University of Macau, Taipa, Macau SAR, People's Republic of China; 3 CAS Engineering Laboratory for Nanozyme, Institute of Biophysics, Chinese Academy of Science, Beijing, People's Republic of China Correspondence: Qi Zhao Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, Macau SAR, 999078, People's Republic of China Email Purpose: Reactive oxygen species (ROS) are a group of signaling biomolecules that play important roles in the cell cycle. When intracellular ROS homeostasis is disrupted, it can induce cellular necrosis and apoptosis. It is desirable to effectively cascade-amplifying ROS generation and weaken antioxidant defense for disrupting ROS homeostasis in tumor microenvironment (TME), which has been recognized as a novel and ideal antitumor strategy. Multifunctional nanozymes are highly promising agents for ROS-mediated therapy. Methods: This study constructed a novel theranostic nanoagent based on 2-x nanozymes (PCCNs) through a facile one-step hydrothermal method. We systematically investigated the photodynamic therapy (PDT)/photothermal therapy (PTT) properties, catalytic therapy (CTT) and glutathione (GSH) depletion activities of PCCNs, antitumor efficacy induced by PCCNs in vitro and in vivo. Results: PCCNs generate singlet oxygen ( 1 O 2 ) with laser (660 nm) irradiation and use catalytic reactions to produce hydroxyl radical (•OH). Moreover, PCCNs show the high photothermal performance under NIR II 1064-nm laser irradiation, which can enhance CTT/PDT efficiencies to increase ROS generation. The properties of O 2 evolution and GSH consumption of PCCNs achieve hypoxia-relieved PDT and destroy cellular antioxidant defense system respectively. The excellent antitumor efficacy in 4T1 tumor-bearing mice of PCCNs is achieved through disrupting ROS homeostasis-involved therapy under the guidance of photothermal/photoacoustic imaging. Conclusion: Our study provides a proof of concept of "all-in-one" nanozymes to eliminate tumors via disrupting ROS homeostasis. Keywords: ROS homeostasis, nanozyme, tumor microenvironment, catalytic therapy, photodynamic/photothermal therapy, photothermal/photoacoustic imaging Reactive oxygen species (ROS), including hydroxyl radical (•OH), superoxide (·O 2 – ), and singlet oxygen ( 1 O 2 ), are a group of signaling biomolecules that play important roles in the cell cycle. 1 , 2 Ironically, cancer cells can utilize ROS to drive cell growth, proliferation and signalling pathway for tumor development. 3 When their concentrations are above a certain level, ROS homeostasis is disrupted by augmenting ROS generation or weakening antioxidant defense, which can induce severe damage to biomolecules and cause cancer cells apoptosis or necrosis. 4–6 Therefore, the disruption of ROS homeostasis through the cascade-amplifying ROS generation and weakening antioxidant defense has been recognized as an effective strategy for anticancer therapy. Photodynamic therapy (PDT), a most common strategy for generating ROS, utilizes photosensitizers to convert overproduced 1 O 2 under laser illumination. This therapy, a noninvasive cancer treatment, has reduced side effects and high selectivity compared to conventional chemo- and radio-therapies. 7–10 However, the clinical application of PDT is hindered by low ROS production in the hypoxic tumor microenvironment (TME) and quick energy attenuation. 11 Therefore, overcoming the limitation of PDT and enhancing the ROS production efficiency is important and imperative to achieve effective antitumor outcomes. Catalytic therapy (CTT) is another recently developed in situ ROS-enhancement method for antitumor treatment. CTT utilizes iron-initiated Fenton, Fenton-like or nanozyme catalytic reactions to efficiently produce the more cytotoxic ROS (•OH) through the disproportionation of H 2 O 2 . 12–14 CTT employs endogenous chemical energy to induce cell death without external energy, avoiding the quick energy attenuation that occurs during penetration of tumor tissue in PDT. 15 Moreover, CTT is selective, -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology